stock-mb-logo-androidstock-mb-logo-ios
Stock Screener App
Free - Play StoreApp Store
InstallInstall
logo
Humacyte IncHUMA
$0.445417.90%-0.0971

Humacyte Inc (HUMA)

Humacyte Inc Stock (HUMA) Forecast

The Humacyte Inc (HUMA) stock price forecast for the next 30 days is generally positive, with an average analyst price target of $0.8409, representing a +88.80% increase from the current price of $0.4454. The highest analyst price target is $1.23, and the lowest is $0.4485.

Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.

12-Month HUMA Price Target
Average 3.20 (+617.94% Upside)

Is Humacyte Inc (HUMA) A Buy Now?

Oscillators
NameValueAction
RSI(14)44.84Neutral
STOCH(9,6)45.99Neutral
STOCHRSI(14)13.64Buy
MACD(12,26)0.01Buy
ADX(14)19.95Neutral
William %R-75.97Neutral
CCI(14)-46.74Neutral
Buy: 2 · Sell: 0 · Neutral: 5Summary: Neutral
Moving Averages
PeriodSimpleExponential
MA10
0.53
Sell
0.51
Sell
MA20
0.48
Sell
0.49
Sell
MA50
0.49
Sell
0.51
Sell
MA100
0.57
Sell
0.59
Sell
MA200
0.77
Sell
0.81
Sell
Buy: 0 · Sell: 10 · Neutral: 0Summary: Sell

According to our latest analysis, HUMA could be considered a Strong Sell, with 17 technical analysis indicators signaling 2 Buy signals, 10 signaling Sell signals and 5 Neutral signals. This might not be a good time to consider opening new positions on HUMA, as trading bearish markets can be challenging and may result in losses.

  1. RSI (Relative Strength Index): The RSI(14) value of 44.84 indicates that HUMA is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
  2. STOCH (Stochastic Oscillator): The STOCH value of 45.99 indicates that HUMA is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
  3. STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 13.64 indicates that HUMA is oversold. This suggests that HUMA price is at or near the lowest level relative to its recent price history.
  4. ADX (Average Directional Index): The ADX value of 19.95 suggests that there may be some movement in price, but it lacks strength or conviction.
  5. CCI (Commodity Channel Index): A CCI(14) value of -46.74 indicates that HUMA is not in oversold or overbought territory. It suggests a neutral sentiment in the short term.

Long-term HUMA price forecast for 2026, 2030, 2035, 2040, 2045 and 2050

Based on our analysis about Humacyte Inc financial reports and earnings history, Humacyte Inc (HUMA) stock could reach $2.56 by 2030, $18.85 by 2040 and $43.02 by 2050. See the projected annual prices until 2050 of the Humacyte Inc stock below:

  • Humacyte Inc (HUMA) is expected to reach an average price of $3.90 in 2035, with a high prediction of $9.63 and a low estimate of $2.25. This indicates an +776.72% change from the last recorded price of $0.4454.
  • Humacyte Inc (HUMA) stock is projected to chart a bullish course in 2040, with an average price target of $12.19, representing an +2,636% change from its current level. The forecast ranges from a conservative $12.67 to a sky-high $18.85.
  • Our analysts predict Humacyte Inc (HUMA) to change +5,297% by 2045, soaring from $23.76 to an average price of $24.04, potentially reaching $30.79. While $23.76 is the low estimate, the potential upside is significant.
  • Humacyte Inc (HUMA) stock is expected to climb by 2050, reaching an average of $36.34, a +8,059% change from its current level. However, a wide range of estimates exists, with high and low targets of $43.02 and $36.54, respectively, highlighting the market's uncertainty.

Humacyte Inc Stock (HUMA) Year by Year Forecast

Humacyte Inc Stock (HUMA) Price Forecast for 2026

The predicted value for Humacyte Inc (HUMA) in 2026 is set at an average of $0.8966. Estimates vary from a peak of $1.53 to a trough of $0.337, indicating an +101.31% surge from the present price of $0.4454.

MonthAverageLowHighChange from today's price
December, 2026$2.60$0.4485$1.23+484.48%

Humacyte Inc Stock (HUMA) Price Forecast for 2027

For 2027, Stockscan's Analyst expects the average price target for Humacyte Inc (HUMA) is $4.61, with a high forecast of $5.95 and a low forecast of $2.69. This indicates an +934.43% increase from the last price of $0.4454.

MonthAverageLowHighChange from today's price
January, 2027$5.01$3.25$4.45+1,024%
February, 2027$4.55$5.04$4.70+921.37%
March, 2027$4.23$4.38$4.20+849.23%
April, 2027$2.63$2.91$3.43+490.67%
May, 2027$3.33$2.69$2.42+647.54%
June, 2027$4.04$4.19$4.31+807.61%
July, 2027$6.02$4.00$5.35+1,251%
August, 2027$5.72$5.83$5.95+1,184%
September, 2027$4.53$4.69$5.56+916.41%
October, 2027$4.38$4.92$4.70+883.39%
November, 2027$5.57$5.10$5.38+1,150%
December, 2027$5.29$5.27$5.28+1,088%

Humacyte Inc Stock (HUMA) Price Forecast for 2028

In 2028, Humacyte Inc (HUMA) is projected to reach an average price of $4.40, with a high projection of $5.97 and a low estimate of $3.05. This indicates an +888.19% rise from the last price of $0.4454.

MonthAverageLowHighChange from today's price
January, 2028$5.26$5.38$5.24+1,081%
February, 2028$6.16$5.56$5.97+1,284%
March, 2028$5.36$5.67$5.92+1,103%
April, 2028$4.87$5.16$5.21+993.22%
May, 2028$4.89$4.96$4.79+997.42%
June, 2028$4.44$4.49$4.50+897.05%
July, 2028$3.38$3.73$4.18+658.77%
August, 2028$3.05$3.85$3.77+585.34%
September, 2028$4.41$4.29$4.36+889.10%
October, 2028$3.97$4.00$4.09+792.26%
November, 2028$3.11$3.32$3.54+597.60%
December, 2028$3.92$3.05$3.41+780.12%

Humacyte Inc Stock (HUMA) Price Forecast for 2029

The 2029 price forecast for Humacyte Inc Stock (HUMA) is $2.43 on average, with a high prediction of $4.70 and a low estimate of $0.1553. This represents an +444.49% increase from the previous price of $0.4454.

MonthAverageLowHighChange from today's price
January, 2029$4.62$3.97$4.34+936.99%
February, 2029$3.97$4.28$4.40+791.71%
March, 2029$3.55$3.80$3.75+698.08%
April, 2029$3.53$3.47$3.28+693.29%
May, 2029$2.75$2.85$3.48+516.59%
June, 2029$1.56$1.66$2.28+250.08%
July, 2029$2.63$2.51$2.40+490.02%
August, 2029$1.61$2.30$2.50+261.67%
September, 2029$0.8662$0.7258$1.56+94.47%
October, 2029$0.1225$0.2925$4.57-72.49%
November, 2029$2.39$0.1553$3.83+437.61%
December, 2029$1.50$0.8958$4.70+235.84%

Humacyte Inc Stock (HUMA) Price Forecast for 2030

Humacyte Inc Stock (HUMA) is expected to reach an average price of $0.8789 in 2030, with a high forecast of $2.56 and a low forecast of $0.1047. This signifies an +97.32% surge from the last price of $0.4454.

MonthAverageLowHighChange from today's price
January, 2030$0.7929$0.2929$2.56+78.02%
February, 2030$0.7299$0.2954$1.65+63.88%
March, 2030$0.477$0.1313$1.68+7.09%
April, 2030$0.1183$0.2798$1.61-73.44%
May, 2030$1.24$0.1047$2.47+177.35%
June, 2030$0.2824$0.1076$1.28-36.60%
July, 2030$0.4163$0.1106$0.7909-6.53%
August, 2030$0.4993$0.9493$0.7735+12.09%
September, 2030$1.97$2.03$2.06+341.84%
October, 2030$2.32$2.23$2.18+421.08%
November, 2030$0.7839$0.8839$1.22+75.99%
December, 2030$0.9225$1.05$1.06+107.13%

Similar to HUMA